Huang, P., Zeng, T., Ban, X., Li, M., Zhang, B., Zhu, Y., . . . Li, Y. (2016). Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy. BMC Cancer.
Chicago-tyylinen lähdeviittausHuang, Pei-Yu, et al. "Expression of EIF5A2 Associates With Poor Survival of Nasopharyngeal Carcinoma Patients Treated With Induction Chemotherapy." BMC Cancer 2016.
MLA-viiteHuang, Pei-Yu, et al. "Expression of EIF5A2 Associates With Poor Survival of Nasopharyngeal Carcinoma Patients Treated With Induction Chemotherapy." BMC Cancer 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.